Volitionrx Limited (VNRX) Reports In-Line Q1 EPS

Volitionrx Limited (NYSE: VNRX) reported Q1 EPS of ($0.13), in-line with the analyst estimate of ($0.13).

Cash and cash equivalents as of March 31, 2016 totaled $17.0 million, compared with $5.9 million as of December 31, 2015.

For earnings history and earnings-related data on Volitionrx Limited (VNRX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c